LabCorp Launches Test for Coronavirus Disease 2019 (COVID-19)
Download PDF
The LabCorp 2019 Novel Coronavirus (COVID-19), NAA Test is for Use by Clinicians with Patients Who Meet COVID-19 Evaluation Criteria
BURLINGTON, N.C.—(BUSINESS WIRE)— LabCorp® (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, is making its LabCorp 2019 Novel Coronavirus (COVID-19), NAA test available today, beginning at 6 p.m. ET, for ordering by physicians or other authorized healthcare providers anywhere in the U.S. The test detects the presence of the underlying virus that causes COVID-19 and is for use with patients who meet current guidance for evaluation of infection with COVID-19.
Stanford Medicine COVID-19 test now in use
The Stanford Clinical Virology Laboratory has deployed an in-house diagnostic test for the virus that causes COVID-19. Rapid identification of infected people could help limit the spread of the virus.
MAR 5 2020
COVID-19
An image from an electron microscope shows SARS-CoV-2 (orange), the respiratory virus that causes COVID-19, emerging from the surface of cells (green) cultured in a lab.
NIAID-RML
The Stanford Health Care Clinical Virology Laboratory has launched a diagnostic test developed for the virus that causes COVID-19.
The test is being used for patients at Stanford Hospital and Lucile Packard Children’s Hospital Stanford suspected of being infected with the respiratory virus SARS-CoV-2, which is spreading globally after being first identified in Wuhan, a city in China, late last year. It is expected to deliver results within 12-24 hours